Cabio Biotech Wuhan Co Ltd
SSE:688089
Cabio Biotech Wuhan Co Ltd
Cash from Operating Activities
Cabio Biotech Wuhan Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Cabio Biotech Wuhan Co Ltd
SSE:688089
|
Cash from Operating Activities
¥176.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
Shanghai Putailai New Energy Technology Co Ltd
SSE:603659
|
Cash from Operating Activities
¥252.1m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
C
|
Cathay Biotech Inc
SSE:688065
|
Cash from Operating Activities
¥569.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
Cash from Operating Activities
¥25.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
3%
|
CAGR 10-Years
20%
|
|
Hoshine Silicon Industry Co Ltd
SSE:603260
|
Cash from Operating Activities
-¥2.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Tianqi Lithium Corp
SZSE:002466
|
Cash from Operating Activities
¥20.9B
|
CAGR 3-Years
172%
|
CAGR 5-Years
46%
|
CAGR 10-Years
49%
|
See Also
What is Cabio Biotech Wuhan Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
176.4m
CNY
Based on the financial report for Dec 31, 2022, Cabio Biotech Wuhan Co Ltd's Cash from Operating Activities amounts to 176.4m CNY.
What is Cabio Biotech Wuhan Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
12%
Over the last year, the Cash from Operating Activities growth was 71%. The average annual Cash from Operating Activities growth rates for Cabio Biotech Wuhan Co Ltd have been 10% over the past three years , 12% over the past five years .